Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Patients with COVID-19
Evidence Based Medicine presented by InpharmD™ · InpharmD™
April 2, 20218m 7s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A randomized study conducted to determine the effect of bamlanivimab monotherapy and combination therapy with bamlanivimab and etesevimab on severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) viral load in mild to moderate COVID-19